Grantham Mayo Van Otterloo & Co. LLC Has $50.02 Million Position in Corteva, Inc. (NYSE:CTVA)

Grantham Mayo Van Otterloo & Co. LLC decreased its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 11.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 878,065 shares of the company’s stock after selling 112,600 shares during the period. Grantham Mayo Van Otterloo & Co. LLC owned 0.13% of Corteva worth $50,015,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in CTVA. Aviva PLC lifted its position in shares of Corteva by 1,424.4% during the 4th quarter. Aviva PLC now owns 411,385 shares of the company’s stock valued at $23,432,000 after acquiring an additional 384,398 shares during the period. Resona Asset Management Co. Ltd. bought a new stake in Corteva in the fourth quarter valued at $11,582,000. World Investment Advisors raised its holdings in shares of Corteva by 46.5% during the fourth quarter. World Investment Advisors now owns 7,941 shares of the company’s stock valued at $452,000 after purchasing an additional 2,520 shares during the period. OneAscent Financial Services LLC boosted its position in shares of Corteva by 16.9% during the 4th quarter. OneAscent Financial Services LLC now owns 5,332 shares of the company’s stock worth $304,000 after purchasing an additional 771 shares in the last quarter. Finally, Huntington National Bank grew its stake in shares of Corteva by 2.2% in the 4th quarter. Huntington National Bank now owns 342,340 shares of the company’s stock valued at $19,500,000 after buying an additional 7,408 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Price Performance

Shares of NYSE CTVA opened at $55.66 on Friday. The company has a market capitalization of $38.02 billion, a PE ratio of 43.15, a PEG ratio of 1.68 and a beta of 0.73. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The stock’s 50 day moving average price is $62.36 and its 200-day moving average price is $60.26. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, equities analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were issued a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a yield of 1.22%. Corteva’s dividend payout ratio (DPR) is presently 52.71%.

Analyst Upgrades and Downgrades

CTVA has been the topic of a number of research reports. KeyCorp upped their price target on Corteva from $68.00 to $70.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Wells Fargo & Company increased their target price on Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a report on Tuesday, January 28th. BNP Paribas upgraded shares of Corteva to a “hold” rating in a research note on Monday, February 10th. Argus upgraded shares of Corteva from a “hold” rating to a “buy” rating and set a $69.00 price objective on the stock in a report on Monday, March 31st. Finally, UBS Group reduced their price objective on shares of Corteva from $74.00 to $73.00 and set a “buy” rating for the company in a report on Friday, January 10th. One analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $68.06.

Insiders Place Their Bets

In other news, insider Brian Titus sold 26,560 shares of the stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the completion of the transaction, the insider now owns 11,347 shares in the company, valued at approximately $723,257.78. This represents a 70.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.14% of the company’s stock.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.